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Membrane-type 1 matrix metalloproteinase (MT1-MMP) is essential for tumor invasion and 
growth. We show here that MT1-MMP induces extracellular signal-regulated kinase (ERK) 
activation in cancer cells cultured in collagen gel, which is indispensable for their 
proliferation. Inhibition of MT1-MMP by MMP inhibitor or small interfering RNA 
suppressed activation of focal adhesion kinase (FAK) and ERK in MT1-MMP-expressing 
cancer cells, which resulted in up-regulation of p21WAF1 and suppression of cell growth in 
collagen gel. Cell proliferation was also abrogated by the inhibitor against ERK pathway 
without affecting FAK phosphorylation. MT1-MMP and integrin αvβ3 were shown to be 
involved in c-Src activation, which induced FAK and ERK activation in collagen gel. These 
MT1-MMP-mediated signal transductions were paxillin dependent, as knockdown of paxillin 
reduced cell growth and ERK activation, and co-expression of MT1-MMP with paxillin 
induced ERK activation. The results suggest that MT1-MMP contributes to proliferation of 
cancer cells in the extracellular matrix by activating ERK through c-Src and paxillin. 
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The extracellular matrix (ECM) is a complex network of structural and functional proteins 
that not only provides cell anchorage but also regulates gene expression, cell proliferation, 
differentiation, and migration [1]. Integrins are the principle cell surface receptors for ECM. 
Integrin clustering induced by cell attachment to ECM promotes formation of cell-matrix 
adhesion and activation of focal adhesion kinase (FAK) and c-Src. When FAK is recruited to 
cell-matrix adhesion by binding with integrin-associated molecules such as talin and paxillin, 
it undergoes autophosphorylation at Tyr 397 and then associates with c-Src and 
phosphatidylinositol-3 kinase. c-Src phosphorylates Tyr 576 and 577 in the catalytic domain 
of FAK, which augments its kinase activity and induces the formation of a multimolecular 
complex, including Shc, JSAP1, and p130Cas, leading to activate mitogen-activated protein 
kinases (MAPK) such as extracellular signal-regulated kinase (ERK) and c-Jun N-terminal 
kinase[1-4]. In fact, elevated FAK and c-Src expression and activity has been associated with 
tumor progression [5]. 
Type I collagen, which is the most abundant protein in the human body, acts as a 
growth-stimulatory protein, when cells are cultured on two-dimensional (2-D) collagen. In 
contrast, cultivation in three-dimensional (3-D) collagen suppresses the proliferation of 
numerous cell types. This growth-suppressive signal may be mediated by integrins, as integrin 
α2β1 mediates fibril collagen-induced inhibition of cell growth [6] and 3-D collagen induces 
down-regulation of cell-matrix adhesion proteins such as FAK, talin, and paxillin, which is 
blocked by integrin α2β1-neutralizing antibody [7]. Recent study has demonstrated that 
reduction of cell-matrix adhesion in 3-D ECM causes growth inhibition [8]. A normal cell 
culture dish is non-flexible with a rigidity of more than 1 gigapascals, whereas 3-D collagen is 
a flexible substrate with the rigidity of 30-100 pascals [7]. Therefore, when cells are plated on 
culture dish or 2-D collagen in the presence of serum, formation of robust cell-matrix 
adhesions is induced, which may function as a scaffold for signaling to promote cell growth, 
which masks the effects of growth factors. In 3-D collagen in which cell-matrix adhesions are 
reduced, the signal from growth factor receptor is required for promotion of cell growth [8]. 
Nevertheless, Integrin-mediated signal from ECM may control cell growth.  
Membrane-type 1 matrix metalloproteinase (MT1-MMP) was originally identified as a 
tumor-specific MMP-2 activator [9], and has been implicated in tumor progression [10]. It is 
now known to activate MMP-2 and -13 and degrade a wide range of ECM components 
including type I collagen, fibronectin, and laminins. This enzyme also processes and interacts 
with membrane-tethered proteins, such as integrins and CD44, which is associated with the 
regulation of tumor cell invasion [10]. The inhibition of MT1-MMP suppresses tumor cell 
invasion both in vitro and in vivo [11-13]. Recent studies have demonstrated that MT1-MMP 
functions as a collagenolytic growth factor that provides cancer cells with the ability to 
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accelerate proliferative responses by overcoming the growth-suppressive signals from 3-D 
collagen [14, 15]. The modulation of the extracellular microenvironment by MT1-MMP may 
play an important role in tumor cell proliferation and invasion, however, the molecular 
mechanism underlying this still remains unknown. 
We have previously reported that MT1-MMP-mediated ECM degradation activates FAK 
and ERK under serum-depleted condition, which in turn stimulates cell migration [11, 16]. In 
this study, we demonstrated that MT1-MMP modulates extracellular microenvironment, 
which induces ERK activation through c-Src and paxillin, and this MT1-MMP-induced ERK 




Materials and methods 
 
Cell culture and reagents. HeLa cells and human oral squamous cell carcinoma HSC-4 
cells were obtained from the Health Science Research Bank (Osaka, Japan). Cells were 
maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% FBS. For 
transfection experiments, cells were transfected with the calcium phosphate method or with 
Lipofectamine 2000 (Invitorgen) according to the manufacturer’s instructions. The reagents 
used were type I collagen (Nitta Gelatin, Osaka, Japan); the inhibitors for Src (PP1 and PP2) 
and MEK (PD98059) (Calbiochem). A synthetic MMP inhibitor (BB94) was a kind gift from 
the Kotobuki Pharmaceutical (Nagano, Japan). The immunological reagents used were 
anti-ERK2, anti-FAK, anti-proliferating cell nuclear antigen (PCNA), and anti-paxillin 
antibodies (BD Biosciences); anti-phospho-p44/42 MAPK, anti-phospho-Y576/577-FAK, 
anti-phospho-Y416-Src, and anti-proline-rich tyrosine kinase 2 (Pyk2) antibodies (Cell 
Signaling); an anti-p21WAF1 antibody (Santa Cruz); an anti-phospho-Y397-FAK antibody 
(BioSource); an anti-Src antibody (Upstate); an anti-tubulin antibody (Sigma): an anti-integrin 
αvβ3 (LM609) antibody (Chemicon). Cells were cultured in 3-D collagen as described 
previously [11]. 
Expression plasmids. An expression plasmid for MT1-MMP tagged with FLAG was 
constructed as previously described.(14) Plasmids encoding the puromycin-resistance gene 
(pHA262pur), pRK-green fluorescence protein (GFP), and pRK-GFP-paxillin were kind gifts 
from Dr. Kenneth M. Yamada (National Institutes of Health, Bethesda, MD, USA). 
Gelatin zymography. The conditioned media from the cells were analyzed by gelatin 
zymography as described previously [11]. 
Immunoblotting. Cells in 3-D collagen were washed with phosphate-buffered saline and 
homogenized in 5× NP-40 lysis buffer containing 250 mM Tris-HCl (pH 7.5), 750 mM NaCl, 
5 mM EGTA, 5 mM phenylmethylsulfonyl fluoride, 10 mM Na3VO4, 10 mM NaF, protease 
inhibitor cocktail (Nacalai tesque), and 5% Nonidet P-40. Cell lysates were separated by 
electrophoresis on SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. 
Cell growth. HSC-4 and HeLa cells were cultured on 2-D collagen or in 3-D collagen with 
96-well culture plates (500 cells/well) for indicated periods. Cells were fed every 3 days. Cell 
growth was determined by assaying viable cell numbers using a Cell Counting Kit-8 (Dojin 
Laboratory, Kumamoto, Japan). The living cell number was assessed by measuring the 
absorbance of OD490 using a SH-1000Lab spectrophotometer (Corona Electric, Ibaraki, 
Japan).  
Small interfering RNA (siRNA)-mediated protein knockdown. The siRNA sequences were 
as follows: mt1-mmp, 5’-AACCAGAAGCUGAAGGUAGTT; fak, 
5’-GCGAUUAUAUGUUAGAGAUAG; paxillin, 5’-CCCUGACGAAAGAGAAGCCCU; 
c-Src-1, 5’-AACAAGAGCAAGCCCAAGGAU; c-Src-2, 
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5’-AAGCACUACAAGAUCCGCAAG. As a control, siRNA duplex with an irrelevant 
sequence was used (Qiagen). HSC-4 cells were transfected with 33.2 nM of siRNA duplexes 
in Opti-MEM using Oligofectamine (Invitrogen), according to the manufacturer’s instructions, 
and were incubated for 48 h. Cells were then detached and cultured in 3-D collagen. 
Real-time PCR quantification. Real-time quantitative PCR experiments were performed as 






MT1-MMP is required for proliferation of cancer cells in 3-D collagen  
 
The role of MT1-MMP in the proliferation of cancer cells was examined. Human 
squamous cell carcinoma HSC-4 cells expressed endogenous MT1-MMP [18], and thereby 
induced the activation of MMP-2, which was stimulated by 3-D collagen culture, and was 
blocked by MMP inhibitor (BB94) treatment (Fig. 1A). In the cells cultured on 
coated-collagen (2-D), ERK was phosphorylated at high level, which was slightly 
down-regulated by treatment with BB94. Cultivation in 3-D collagen markedly attenuated 
ERK activation, which was further suppressed by BB94 treatment. Phosphorylation of FAK at 
Tyr 576 and 577 was quite proportional to ERK activation. FAK phosphorylation at Tyr 397 
was also attenuated by BB94-treatemnet in 2-D culture, but was reduced only faintly in 3-D 
collagen culture. Proportional to the attenuation of phosphorylation of FAK at Tyr 576 and 
577 and ERK by 3-D culture and/or BB94 treatment, the expression of the cyclin-dependent 
kinase inhibitor p21WAF1 was increased, whereas the expression of PCNA, which is expressed 
in replicating cells, showed reverse co-relation to p21WAF1 expression. HSC-4 cell growth on 
2-D collagen was not affected by BB94 treatment; however, 3-D collagen culture reduced cell 
proliferation to 37% of that on 2-D collagen, which was further suppressed to 17% by 
treatment with BB94 (Fig. 1B). To confirm the role of MT1-MMP, siRNA-mediated 
knockdown of protein expression was employed. We achieved > 90% suppression of 
MT1-MMP mRNA upon transfection of MT1-MMP siRNA (data not shown), and MMP-2 
activation by HSC-4 cells was completely blocked by MT1-MMP knockdown (Fig. 1C). As 
expected, knockdown of MT1-MMP resulted in suppression of FAK and ERK 
phosphorylation, which induced p21WAF1 expression. Inhibition of ERK pathway by PD98059 
treatment also induced p21WAF1 expression without affecting FAK phosphorylation. As shown 
in Fig. 1D, growth of HSC-4 cells in 3-D collagen was impeded by inhibition of MT1-MMP 
by siRNA or BB94, or ERK pathway by PD98059. These results show that MT1-MMP 
induces ERK activation, which plays an important role in proliferation of cancer cells in 3-D 
collagen. 
 
c-Src is involved in MT1-MMP-mediated ERK activation  
 
We found that the inhibition of MT1-MMP suppresses FAK phosphorylation at Tyr 576 
and 577 in 3-D collagen, which are sites phosphorylated by c-Src, resulting in enhancement of 
FAK activity (Fig. 1A). It suggests that c-Src may participate in MT1-MMP-mediated FAK 
and ERK activation. To investigate it, the effect of MT1-MMP knockdown by siRNA on c-Src 
activation was examined (Fig. 2A). Knockdown of MT1-MMP reduced MMP-2 activation 
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and c-Src phosphorylation at Tyr 416 in 3-D collagen. Next, the effect of c-Src inhibition on 
FAK and ERK activation was tested. The blockade of c-Src by its inhibitors attenuated 
phosphorylation of FAK and ERK in HSC-4 cells cultured in 3-D collagen as BB94 did (Fig. 
2B). In addition, phosphorylation of FAK and ERK was remarkably inhibited in the cells 
transfected with siRNA for c-Src (Fig. 2C). Activation of c-Src is induced by forming the 
complex with FAK or directly by engagement of integrins that recognize RGD containing 
protein[19]. To seek the pathway to activate c-Src, HSC-4 cells were cultured with integrin 
αvβ3-neutralizing antibody (LM609) in 3-D collagen. Cultivation of cells with this 
neutralizing antibody but not negative control antibody resulted in suppression of c-Src 
phosphorylation as BB94 did (Fig. 2D). Concomitantly, ERK activation was impeded by 
treatment with integrin αvβ3-neutralizing antibody and BB94. These results demonstrate that 
MT1-MMP is required for complete activation of c-Src through integrin αvβ3 in 3-D collagen, 
which may subsequently induce FAK and ERK activation. 
 
Paxillin plays an important role in MT1-MMP-mediated ERK activation 
 
To investigate the mechanism by which MT1-MMP regulates ERK activation through 
c-Src, HSC-4 cells were tranfected with siRNA for either FAK or paxillin, which are the 
substrates of c-Src, and were cultured in 3-D collagen. ERK activation was significantly 
down-regulated by knockdown of paxillin but not FAK. The expression level of FAK-related 
protein Pyk2, which can compensate some FAK functions, was not altered in these cells. 
Knockdown of paxillin remarkably reduced HSC-4 cell growth in 3-D collagen, although 
FAK knockdown did not significantly affect it (Fig. 3B). Next, to test whether co-expression 
of MT1-MMP and paxillin induces ERK activation in 3-D collagen, HeLa cells, which do not 
express MT1-MMP, were transfected with MT1-MMP plasmid and cultured in 3-D collagen 
(Fig. 3C). Expression of MT1-MMP or GFP-paxillin alone was not enough to induce ERK 
activation, and co-expression of MT1-MMP and GFP-paxillin induced ERK activation. 
Co-expression of GFP-paxillin did not significantly affect MMP-2 activation by MT1-MMP. 
These results indicate that paxillin is involved in MT1-MMP-mediated ERK activation 






We have previously shown that ECM degradation at cell-matrix adhesions by MT1-MMP 
accelerates cell-matrix adhesion turnover, which stimulates FAK and ERK activation, 
resulting in enhancement of cell migration [11, 13, 16]. The present study confirms and 
extends our previous studies to demonstrate that MT1-MMP stimulates ERK activation in 3-D 
collagen, which is indispensable for proliferation of cancer cells. It is well documented that 
the interaction between collagen fibrils and integrin α2β1 generates the growth-suppressive 
signals in normal epithelial or cancer cells cultured in 3-D collagen [7, 20-22], which can be 
abrogated by pericellular collagenolysis [14, 15]. We represent that MT1-MMP induces c-Src 
activation in 3-D collagen by modulating extracellular microenvironment, which subsequently 
activates paxillin to scaffold signaling molecules for ERK pathway and thus leads to escape 
cells from growth-suppressive signals.  
In this study, we observed that ERK suppression by MMP inhibitor and MT1-MMP 
knockdown induces p21WAF1 expression and PCNA repression in cancer cells (Fig. 1). The 
increase of p21WAF1 and the decrease of PCNA expression are associated with the growth 
inhibition of melanoma and hepatic stellate cells on cross-linked or collagenase-resistant 
collagen [20, 21, 23]. Inhibition of MEK-ERK pathway down-regulates expression of PCNA 
and DNA methyltransferase 1, and induces promoter demethylation of the p21WAF1 gene, 
which up-regulates its mRNA and protein expression in colon cancer cells [24]. Our results 
also showed that inhibition of ERK pathway by PD98059 induces p21WAF1 expression without 
affecting FAK phosphorylation. These effects resulted in growth suppression of cancer cells. 
Thus, MT1-MMP-mediated ERK activation may promote cell proliferation at least in part by 
down-regulating p21WAF1. To escape from a quiescent state induced by 3-D collagen and to 
initiate growth, cancer cells may activate MT1-MMP axis. 
Although phosphorylation of FAK at Tyr 397, 576, and 577 was shown to be regulated by 
MT1-MMP, the level of phosphorylation at Tyr 576 and 577 of FAK, which are 
phosphorylated by c-Src, was remarkably reduced by 3D-collagen culture, and correlates with 
ERK activation. Therefore, c-Src is suggested to be involved in MT1-MMP-mediated ERK 
activation. We found that MT1-MMP is required for complete activation of c-Src by its 
autophosphorylation at Tyr 416 located in the activation loop of the catalytic center, which 
induces FAK and ERK activation in 3-D collagen (Fig. 2). Activation of c-Src is induced by 
forming the complex with FAK or directly by engagement of integrin αIIbβ3, α4β1, or αvβ3, 
which recognize RGD containing protein such as fibronectin and vitronectin [19]. Notably, 
the expression of MT1-MMP in prostate cancer LNCaP cells induces fibronectin expression 
in 3-D collagen [25], and intact type I collagen is a poor ligand for integrin αvβ3, while 
degraded collagen exposes RGD epitopes [26]. In the present study, treatment of cancer cells 
with integrin αvβ3-neutralizing antibody impaired activation of c-Src, FAK and ERK in 3-D 
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collagen. Thus, MT1-MMP may induce expression of RGD-containing proteins and/or 
exposure of RGD epitopes in collagen fibrils, which may activate c-Src through integrins, 
including αvβ3.  
 Mouse embryonic fibroblasts derived from paxillin-deficient mouse display reduced cell 
migration and activation of FAK and ERK [27]. Paxillin is known to function as a scaffold for 
hepatocyte growth factor-stimulated ERK activation with binding to c-Raf, MEK, and ERK, 
which is initiated through hepatocyte growth factor-induced c-Src activation [28]. A recent 
study reported that paxillin is mutated and amplified in roughly 20% of lung cancers [29]. We 
found that knockdown of paxillin but not FAK reduces ERK activation and growth of cancer 
cells in 3-D collagen, and that co-transfection of MT1-MMP and paxillin induces ERK 
activation in 3-D collagen (Fig. 3). A previous study by other group demonstrated that ERK 
activation is independent from the FAK-regulated pathway in fibroblasts cultured in 
cell-derived 3-D matrix [30]. These results strongly suggest that paxillin may function as a 
down-stream effecter for MT1-MMP-mediated ERK activation through c-Src. Paxillin has 
been also implicated in cell survival, as the interaction of paxillin with FAK or Bcl-2 
promotes cell survival [31]. Our results showing that knockdown of paxillin severely 
attenuates growth of cancer cells in 3-D collagen may be caused by suppression of both ERK 
activation and cell survival. MT1-MMP-activated c-Src through integrins including αvβ3 may 
utilize paxillin as the scaffold for ERK activation, which overcomes growth suppressive 
signal to produce p21WAF1 in 3-D collagen (Fig. 4).  
In conclusion, we demonstrated that the enhanced expression of MT1-MMP in cancer 
cells contributes to not only invasion, but also proliferation in 3-D matrix by activating ERK 
pathway through c-Src and paxillin. 
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Fig. 1. MT1-MMP-dependent growth of HSC-4 cells in 3-D collagen. (A) HSC-4 cells were 
cultured on 2-D or in 3-D collagen with or without BB94 (10 μM) for 2 days. The conditioned 
media were analyzed by gelatin zymography. Cell lysates were analyzed by immunoblotting 
using anti-phospho-p44/42 MAP kinase (pERK), anti-ERK2, anti-phospho-Y397-FAK 
(pY397-FAK), anti-phospho-Y576/577-FAK (pY576/7-FAK), anti-FAK, anti-p21WAF1, 
anti-PCNA, or anti-tubulin antibodies. (B) HSC-4 cells (1×103 cells/well) were cultured on 
2-D or in 3-D collagen with or without BB94 for 7 days. Cell numbers were normalized to 
growth levels of 2-D-cultured cells without BB94. Columns, mean; bars, SE; n=12. *, P < 
0.0001. (C) HSC-4 cells were cultured with scrambled siRNA (Scr) or MT1-MMP siRNA 
(MT1), DMSO BB94, or PD98059 in 3-D collagen for 24 h. The conditioned media were 
analyzed by gelatin zymography. Cells lysates were analyzed by immunoblotting using 
anti-phospho-Y397-FAK (pY397-FAK), anti-FAK, anti-phospho-p44/42 MAP kinase (pERK), 
anti-ERK2, or anti-p21WAF1 antibodies. NS, non-specific immunoreactive bands. (D) HSC-4 
cells (6×104 cells/well) were cultured as above for 3 days. Cell number was normalized to that 
of cells transfected with Scr-siRNA. Columns, mean; bars, SE; n=12. *, P < 0.0001.  
 
Fig. 2. c-Src is involved in MT1-MMP-mediated ERK activation. (A) HSC-4 cells (1×105 
cells) treated with scrambled siRNA (Scr) or MT1-MMP siRNA (MT1) were cultured in 3-D 
collagen for 24 h. Cells lysates were analyzed by immunoblotting using 
anti-phospho-Y416-Src (pY416-Src), anti-Src, and anti-tubulin antibodies. (B) HSC-4 cells 
were cultured in 3-D collagen with DMSO, BB94, PP1 or PP2 (10 μM) for 48 h. The 
conditioned media were analyzed by gelatin zymography. Cells lysates were analyzed by 
immunoblotting using anti-phospho-Y576/577-FAK (pY576/7-FAK), anti-FAK, 
anti-phospho-p44/42 MAP kinase (pERK), or anti-ERK2 antibodies. (C) HSC-4 cells 
transfected with scrambled siRNA (Scr), c-Src siRNA1 (Src-1), or c-Src siRNA2 (Src-2) were 
cultured in 3-D collagen for 24 h. Cells lysates were analyzed by immunoblotting using 
anti-Src, anti-tubulin, anti-phospho-Y576/577-FAK (pY576/7-FAK), anti-FAK, 
anti-phospho-p44/42 MAP kinase (pERK), or anti-ERK2 antibodies. (D) HSC-4 cells were 
cultured in 3-D collagen with DMSO, BB94, or anti-integrin αvβ3 blocking antibody (LM609) 
or negative control antibody (10 μg/mL) for 48 h. The conditioned media were analyzed by 
gelatin zymography. Cells lysates were analyzed by immunoblotting using 
anti-phospho-Y416-Src (pY416-Src), anti-Src, anti-phospho-p44/42 MAP kinase (pERK), 
anti-ERK2, and anti-tubulin antibodies. 
 
Fig. 3. Paxillin plays an important role in MT1-MMP-mediated ERK activation. (A) HSC-4 
cells treated with scrambled siRNA (Scr), FAK siRNA (FAK), or paxillin siRNA (Paxillin) 
15 
 
were cultured in 3-D collagen for 48 h. The conditioned media were analyzed by gelatin 
zymography. Cells lysates were analyzed by immunoblotting using anti-FAK, anti-paxillin, 
anti-tubulin, anti-phospho-p44/42 MAP kinase (pERK), or anti-ERK2 antibodies. (B) HSC-4 
cells (6×104 cells/well) transected with indicated siRNA were cultured in 3-D collagen for 3 
days. Cell numbers are normalized to growth levels of cells transfected with Scr-siRNA. 
Columns, mean; bars, SE; n=12. *, P < 0.0001. (C) HeLa cells were co-transfected with 
MT1-MMP and GFP-paxillin plus pHA262Pur as described above. After 24 h transfection, 
cells were cultured in 10% FBS/DMEM containing puromycin (1 μg/mL) for 48 h. Then cells 
were cultured in 3-D collagen for 24 h. The conditioned media were analyzed by gelatin 
zymography. Cells lysates were analyzed by immunoblotting using anti-paxillin, 
anti-phospho-p44/42 MAP kinase (pERK), or anti-ERK2 antibodies.  
 
Fig. 4. A model for MT1-MMP-dependent cell growth in 3-D collagen culture. In 3-D 
collagen matrix, cell growth is suppressed by integrin α2β1-mediated signals. Pericellular 
collagenolysis by MT1-MMP not only provides the space for cells to proliferate but also 
regulates gene expression and ERK activation through integrin αvβ3, c-Src and paxillin, and 
abrogates growth-suppressive signals by collagen fibrils, which consequently reduces p21WAF1 
expression and recovers cell growth. 
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